insights_auto
Why is SOBI down 2,63%?
Dive Deeperchevron_right
SOBI:STO
Swedish Orphan Biovitrum AB (publ)
474,20 SEK
arrow_downward
-2,63%(-12,80) 1D
13 қар., 17:29:42 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SOBI...
Open
487,20 SEK
High
490,80 SEK
Low
474,20 SEK
Mkt. cap
169,59 млрд
Avg. vol.
405,15 м.
Volume
575,00 м.
P/E ratio
25,19
52-wk high
507,00 SEK
52-wk low
314,40 SEK
EPS
18,83 SEK
Shares outstanding
357,64 млн
No. of employees
2 мың
Open
487,20 SEK
High
490,80 SEK
Low
474,20 SEK
Mkt. cap
169,59 млрд
Avg. vol.
405,15 м.
Volume
575,00 м.
P/E ratio
25,19
52-wk high
507,00 SEK
52-wk low
314,40 SEK
EPS
18,83 SEK
Shares outstanding
357,64 млн
No. of employees
2 мың
News stories
From web sources and news partners
www.marketscreener.com
·
9 сағат бұрын
Sobi's outgoing CEO Guido Oelkers sells shares for SEK 68m (update)
www.marketscreener.com
·
10 сағат бұрын
Raised earnings forecasts for Sobi after strong report, price target adjusted downward
Profile
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
About Swedish Orphan Biovitrum AB (publ)